Genomics of Drug Sensitivity in Cancer Dasatinib
Synonyms BMS-354825-03, BMS-354825, Sprycel
Targets ABL, SRC, Ephrins, PDGFR, KIT
Target pathway Other
PubCHEM ID 3062316
Jsmol
Download molecule 3062316
PUBCHEM IUPAC INCHI InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)
Smiles ClC4(=C(NC(=O)C=3(SC(NC1(=NC(=NC(=C1)N2(CCN(CCO)CC2))C))=NC=3))C(=CC=C4)C)
Cluster number 121
calculated LogS -4,701
Molecular weight 488,014
calculated LogP 3,6259
H-Acceptors 9
H-Donors 3
Ro5 violations 0
Druglikeness 8,0376
DrugScore 0,195597519307076
Mutagenic none
Tumorigenic none
Reproductive Effective high
Irritant high
Fish Toxicity High FHMT
Fish Toxicity2 1,5068
Rat Acute Toxicity 2,4772
Acute Oral Toxicity III
Caco-2 Permeability Caco2-
Caco-2 Permeability2 0,7965
P-glycoprotein Substrate Substrate
P-glycoprotein Inhibitor Inhibitor
P-glycoprotein Inhibitor2 Inhibitor
Human Ether-a-go-go-Related Gene Inhibition Weak inhibitor
Human Ether-a-go-go-Related Gene Inhibition2 Inhibitor
Tetrahymena Pyriformis Toxicity High TPT
Tetrahymena Pyriformis Toxicity2 0,5822
AMES Toxicity Non AMES toxic
CYP450 2C9 Substrate Non-substrate
CYP450 3A4 Substrate Substrate
CYP450 3A4 Inhibitor Inhibitor
CYP450 2C19 Inhibitor Inhibitor
CYP450 2C9 Inhibitor Inhibitor
CYP450 2D6 Inhibitor Non-inhibitor
CYP450 1A2 Inhibitor Non-inhibitor
CYP450 2D6 Substrate Non-substrate
Biodegradation Not ready biodegradable
Carcinogenicity (Three-class) Non-carcinogens
Carcinogens Non-required
Blood-Brain Barrier BBB-
CYP Inhibitory Promiscuity High CYP Inhibitory Promiscuity
Honey Bee Toxicity Low HBT
Renal Organic Cation Transporter Non-inhibitor
Subcellular localization Mitochondria
Human Intestinal Absorption HIA+
Aqueous solubility -3,764
Information useful only for research purposes.